Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mgta-145 (4 trials)
mgta-456 (1 trial)
plerixafor (mozobil) (3 trials)
mgta-117 (1 trial)
Disease (Phase 2)
Metabolic Diseases (Phase 2)
Renal Insufficiency (Phase 1)
Trials (6 total)
Trial APIs (4 total)